The Michigan State University Board of Trustees approved a handful of key personnel changes at its Feb. 16 meeting.
Andrea Amalfitano, MSU Clinical and Translational Sciences Director, has been appointed as interim dean of the College of Osteopathic Medicine.
The trustees approved the appointment of Bill Beekman as interim athletic director. Beekman most recently served as acting president at MSU and will remain vice president and secretary of the Board of Trustees.
The trustees also approved the appointment of Carol Viventi to serve as vice president and special counsel to Interim President John Engler.
MSU head football coach Mark Dantonio has been rewarded with a revised contract, according to a joint announcement by MSU Interim Athletics Director Bill Beekman and MSU Interim President Engler. The contract renewal extension will be effective from Jan. 15, 2023 to Jan. 14, 2024.
Trustees were presented with plans for MSU’s new health structure, which targets safety, quality and transparency. The presentation included the new structure for the university’s health colleges, clinical practice and student wellness programs, including two leadership appointments.
Norman J. Beauchamp Jr., dean of the College of Human Medicine, is expected to be appointed to the newly created position of associate provost and assistant vice president for health affairs. Anthony M. Avellino, chief executive officer of OSF Healthcare Illinois Neurological Institute, will assume the roles of assistant provost for student health, wellness and safety and MSU HealthTeam chief medical officer.
Addressing campus construction, the trustees gave authorization to proceed with the next phase of the Facility for Rare Isotope Beams. Construction can begin on the high rigidity spectrometer and isotope harvesting experimental vault, with a budget of $22.5 million. The new vault will comprise 31,000 square feet and provide a highbay for isotope harvesting and space to accommodate a new large-scale detector.
Along with approving the vault, the trustees gave authorization to proceed with FRIB’s cryogenic assembly building. The $12.4 million project includes a 14,000 square foot building for the assembly, testing, cooling and repair of cryomodules and beam line magnets.
